FDA Approved: DIAZEPAM — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application to Chartwell RX, LLC for diazepam oral solution (concentrate), authorizing a generic version of this formulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Withdrawal Syndrome
• Anxiety Disorders
• Muscle Spasticity
• Panic Disorder
• Seizure Disorders

Drugs mentioned

• Diazepam Oral Solution (Concentrate) (Diazepam oral solution (concentrate))

Snippet

SUPPL AP for DIAZEPAM (DIAZEPAM ORAL SOLUTION (CONCENTRATE))